You can buy or sell Precipio and other stocks, options, ETFs, and crypto commission-free!
Precipio, Inc. Common Stock, also called Precipio, is a cancer diagnostics company, which engages in the development and provision of a platform designed to eradicate the problem of misdiagnosis. Read More Its products and services include MX-ICP and HemeScreen HRM kits, SmartPath, SmartGen, and ICP liquid biopsy testing. The company was founded in March 1997 and is headquartered in New Haven, CT.
New Haven, Connecticut
52 Week High
52 Week Low
Seeking AlphaMay 7
Precipio, Inc. (PRPO) CEO Ilan Danieli on Shareholder Update Conference (Transcript)
Associated PressMay 6
Precipio Conducts IV-Cell™ Validation Trial with a Prominent Laboratory
NEW HAVEN, Conn., May 06, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), announced that it is in the process of completing a trial of its Proprietary IV-Cell media with a significant laboratory (name undisclosed at this time). The purpose of the trial is to demonstrate the capabilities of Precipio’s proprietary IV-Cell media within the cytogenetics department alongside the existing media used; and compare results. Upon successful completion of the study, Precipio and...
-$1.01 per share
-$0.23 per share